Premium
Bempedoic acid for primary hypercholesterolaemia
Author(s) -
Chaplin Steve
Publication year - 2021
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1888
Subject(s) - medicine , primary (astronomy) , physics , astronomy
Bempedoic acid (Nilemdo) is a new lipid‐lowering therapy for the treatment of primary hypercholesterolaemia and mixed dyslipidaemia. This article summarises its mechanism of action, clinical trial efficacy and side‐effects.